Login
Home / 002620.KS : KSC
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Jeil Pharma Holdings Inc

₩7490 -$660.00 (-8.10%)
KSC · 15 Sep 2026 06:30 UTC
Previous Close
₩7570
Day Range
₩7400₩7510
Year Range
₩6050₩9850
Market Cap
114.98B
AVG Volume
11.1K
Trailing/Forward PE
13.62/-
PEG ratio
0.2
Dividend Yield
0.93%
Next Earnings Date
-
Primary Exchange
Korea ExchangeKR
Revenue (KRW)
0100B200B300B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Net Income (KRW)
-40B-20B020B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Operating Income (KRW)
-20B-10B010B20B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EBITDA (KRW)
-100B-50B050B100B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash Flows (KRW)
-20B-10B010B20B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EPS (KRW)
-3000-2000-10000100024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Expenses (KRW)
020B40B60B80BR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash & Debt (KRW)
050B100B150B200BCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Debt ratios
-10-50524 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Margins
0%20%40%60%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Return on Capital
-10%-7.5%-5%-2.5%0%2.5%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Shares Outstanding
05M10M15M20M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Dividends (KRW)
0100200300Dec 16Dec 17Dec 18Dec 19Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25
Book Value Per Share (KRW)
02000040000600008000024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Total Assets (KRW)
0250B500B750B1T24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PE Ratio
0204060med 32.56Dec 19Apr 21Jul 21Nov 21Feb 22Jun 26Sep 26
Free Cash Flow Yield
-20%-10%0%10%med -6.64%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Price to Sales
0.050.10.150.20.25med 0.17Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
EV/EBITDA
0255075100med 9.6Dec 21Apr 22May 24Aug 25Nov 25Mar 26Jun 26
Price/Operating Cashflow
0100200300med 13.76Jun 22Jul 24Jan 25May 25Feb 26Jun 26Sep 26
Price to Book
0.10.20.30.40.5med 0.28Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Jeil Pharma Holdings Inc
002620.KS
Stockpicker

Video analysis: 002620.KS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.